GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results